GWS
MDCO

Glassman Wealth Services’s Medicines Co MDCO Stock Holding History

Glassman Wealth Services’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-49
Closed -$2K – 1642
2019
Q3 		$2K Buy
49
+11
+29% +$439 ﹤0.01% 763
2019
Q2 		$1K Hold
38
– – ﹤0.01% 1017
2019
Q1 		$1K Buy
+38
New +$896 ﹤0.01% 984

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Glassman Wealth Services's MDCO Position: Q4 2019 in Review

Glassman Wealth Services sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 49 shares — an estimated $2K sold.

Glassman Wealth Services first reported a position in MDCO in Q1 2019 and held it in 3 quarters. The position peaked at $2K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Glassman Wealth Services reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Glassman Wealth Services sold 49 Medicines Co shares in Q4 2019, an estimated $2K.
  • Glassman Wealth Services first reported a position in Medicines Co in Q1 2019 and held it in 3 quarters.
  • Glassman Wealth Services's Medicines Co position peaked at $2K in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Glassman Wealth Services's 13F filing for Q4 2019, filed 7 Feb 2020.